Home » Topics » BioWorld Science

BioWorld Science
RSS

Lundbeck's Lu-AF82422 for Parkinson's enters the clinic

Aug. 7, 2018

Mebias Discovery patents new compounds for pain

Aug. 7, 2018

Aevitas Therapeutics, University of Pennsylvania enter sponsored research agreement

Aug. 7, 2018

Topical curcumin nanocarriers provide retinal protection in preclinical eye disease models

Aug. 7, 2018

Ovid Therapeutics reports topline data from STARS study in Angelman syndrome

Aug. 7, 2018

First patient treated in phase I of HPN-424 in metastatic castration-resistant prostate cancer

Aug. 7, 2018

Researchers discover potent and selective histone deacetylase 11 inhibitors

Aug. 7, 2018

MediciNova, University of Cambridge to study ibudilast in degenerative cervical myelopathy

Aug. 7, 2018

Final results from PROPEL study support further clinical development of PTG-100 in UC

Aug. 7, 2018

Almac, Elasmogen and Innovate UK to develop VNAR-based oncology platform

Aug. 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...